Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
about
Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trialMiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
P2860
Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Myocyte membrane and microdoma ...... olerance and cardioprotection.
@en
Myocyte membrane and microdoma ...... olerance and cardioprotection.
@nl
type
label
Myocyte membrane and microdoma ...... olerance and cardioprotection.
@en
Myocyte membrane and microdoma ...... olerance and cardioprotection.
@nl
prefLabel
Myocyte membrane and microdoma ...... olerance and cardioprotection.
@en
Myocyte membrane and microdoma ...... olerance and cardioprotection.
@nl
P2093
P2860
P921
P1476
Myocyte membrane and microdoma ...... olerance and cardioprotection.
@en
P2093
Eugene F Du Toit
Hemal H Patel
Jake Russell
Jason N Peart
P2860
P2888
P356
10.1186/S12933-017-0638-Z
P407
P5008
P577
2017-12-04T00:00:00Z
P6179
1093162808